Re: Long-Term Safety, Tolerability and Efficacy of Flexible-Dose Fesoterodine in Elderly Patients with Overactive Bladder: Open-Label Extension of the SOFIA Trial Editorial Comment

被引：0
|
作者：
Griebling, Tomas L.
机构：
来源：
JOURNAL OF UROLOGY | 2014年 / 192卷 / 06期
关键词：
D O I：
10.1016/j.juro.2014.09.064
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1766 / 1766
页数：1
相关论文
共 50 条
  • [31] MPOWERED Trial Open-Label Extension: Long-term Efficacy and Safety Data for Oral Octreotide Capsules in Acromegaly
    Fleseriu, Maria
    Molitch, Mark
    Dreval, Alexander
    Pokramovich, Yulia
    Bondar, Irina
    Poteshkin, Yury
    Macut, Djuro
    Obermayer-Pietsch, Barbara
    Gilgun-Sherki, Yossi
    Haviv, Asi
    Biermasz, Nienke
    Strasburger, Christian J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (12): : 3214 - 3222
  • [32] Long-Term Safety and Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Dravet Syndrome in an open-label, Extension Trial
    Halford, Jonathan
    Scheffer, Ingrid
    Nabbout, Rima
    Sanchez-Carpintero, Rocio
    Malawsky, Yael Shiloh
    Wong, Matthew
    Checketts, Daniel
    VanLandingham, Kevan
    NEUROLOGY, 2019, 92 (15)
  • [33] Long-term safety and tolerability of open-label cariprazine in patients with bipolar I disorder
    Ketter, T. A.
    Sachs, G. S.
    Lu, K.
    Ruth, A.
    Laszlovszky, I.
    Nagy, K.
    Starace, A.
    Durgam, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S377 - S377
  • [34] Long-term safety and tolerability of open-label cariprazine in patients with bipolar I disorder
    Ketter, T. A.
    Sachs, G.
    Lu, K.
    Laszlovszky, I.
    Nagy, K.
    Starace, A.
    Durgam, S.
    BIPOLAR DISORDERS, 2013, 15 : 134 - 134
  • [35] An Open-Label, Long-Term Safety and Tolerability Trial of Diclofenac Sodium I% Gel in Patients with Knee Osteoarthritis
    Peniston, John H.
    Gold, Morris S.
    Alwine, Lawrence K.
    PHYSICIAN AND SPORTSMEDICINE, 2011, 39 (03): : 31 - 38
  • [36] Long-term safety and tolerability of lacosamide monotherapy in patients with epilepsy: Results from a multicenter, open-label trial
    Ben-Menachem, Elinor
    Dominguez, Jacqueline
    Szasz, Jozsef
    Beller, Cynthia
    Howerton, Charles
    Jensen, Lori
    McClung, Carrie
    Roebling, Robert
    Steiniger-Brach, Bjorn
    EPILEPSIA OPEN, 2021, 6 (03) : 618 - 623
  • [37] Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease
    Friedman, Joseph H.
    Berman, Robert M.
    Goetz, Christopher G.
    Factor, Stewart A.
    Ondo, William G.
    Wojcieszek, Joanne
    Carson, William H.
    Marcus, Ronald N.
    MOVEMENT DISORDERS, 2006, 21 (12) : 2078 - 2081
  • [38] Long-term treatment with darifenacin for overactive bladder: results of a 2-year, open-label extension study
    Haab, Francois
    Corcos, Jacques
    Siami, Paul
    Glavind, Karin
    Dwyer, Peter
    Steel, Michael
    Kawakami, Fernando
    Lheritier, Karine
    Steers, William D.
    BJU INTERNATIONAL, 2006, 98 (05) : 1025 - 1032
  • [39] Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study
    Ivy, Dunbar
    Beghetti, Maurice
    Juaneda-Simian, Ernesto
    Ravindranath, Ramiya
    Lukas, Mary Ann
    Machlitt-Northen, Sandra
    Scott, Nicola
    Narita, Jun
    Berger, Rolf M. F.
    EUROPEAN JOURNAL OF PEDIATRICS, 2024, 183 (05) : 2123 - 2130
  • [40] Long-term safety and tolerability of memantine: an open-label extension study in patients with mild to moderate Alzheimer's disease
    Bakchine, S.
    Rainer, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S529 - S529
12345